Advocacy intelligence hub — real-time data for patient organizations
Ashley Shoemaker — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Emily L Germain-Lee, MD, M.D
Connecticut Children's Medical Ctr. and Univ. of Connecticut School of Medicine
📍 FARMINGTON, CT
Ashley Shoemaker, MD
Vanderbilt University Medical Center
📍 Nashville, Tennessee
Smita Jha, M.D., M.D
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
📍 BETHESDA, MD
Agnès LINGLART
Inserm U1169
Ashley H Shoemaker, MD, MSCI
Vanderbilt University
AMITA SHARMA, MD
Massachusetts General Hospital